Concordia Healthcare Corp. to host second quarter 2015 results conference call

TORONTO, July 29, 2015 /CNW/ - Concordia Healthcare Corp. ("Concordia" or "the Company") (NASDAQ: CXRX) (TSX: CXR), today announced it will release its second quarter 2015 financial results after market close on Thursday, August 13, 2015.

The Company will subsequently hold a conference call on Friday, August 14, 2015, at 8:30 a.m. ET hosted by Mr. Mark Thompson, Chairman and Chief Executive Officer, Mr. Adrian de Saldanha, Chief Financial Officer, and Mr. Wayne Kreppner, President and Chief Operating Officer. A question-and-answer session will follow the corporate update.

CONFERENCE CALL DETAILS

DATE:

Friday, August 14, 2015

TIME:

8:30 a.m. ET

DIAL-IN NUMBER:

(647) 427-7450 or (888) 231-8191

TAPED REPLAY:

(416) 849-0833 or (855) 859-2056

REFERENCE NUMBER:

94578329

This call is being webcast and can be accessed from the Concordia website at www.concordiarx.com or by going to:

http://event.on24.com/r.htm?e=1028822&s=1&k=FE8E5E6629D5B5CFD275FA284F328C7A

An archived replay of the webcast will be available for 90 days.

About Concordia

Concordia is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs. Concordia's legacy pharmaceutical division, Concordia Pharmaceuticals Inc., consists of a portfolio of branded products and authorized generic contracts, including branded products such as Nilandron®, for the treatment of metastatic prostate cancer; Dibenzyline®, for the treatment of pheochromocytoma; Lanoxin®, for the treatment of mild-to-moderate heart failure and atrial fibrillation; Plaquenil®, for the treatment of lupus and rheumatoid arthritis, Donnatal® for the treatment of irritable bowel syndrome and Zonegran® (zonisamide) for treatment of partial seizures in adults with epilepsy. Concordia's orphan drugs division, Concordia Laboratories Inc., owns Photofrin®. Photofrin® is marketed by Pinnacle Biologics, Inc. in the United States.

Concordia operates out of facilities in Oakville, Ontario; Bridgetown, Barbados; Roanoke, Virginia and has a specialty healthcare distribution (SHD) division that operates out of Kansas City, Missouri. Pinnacle Biologics Inc. is located in Chicago, Illinois.

SOURCE Concordia Healthcare Corp.

For further information: please visit www.concordiarx.com or contact: Adam Peeler, NATIONAL Equicom, 416-815-0700 x 225, apeeler@tmxequicom.com

Organization Profile

Concordia Healthcare Corp.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890